Is There Room for Personalized Medicine in Small-Cell Lung Cancer (SCLC)? Remarkable Activity of Pazopanib in Refractory FGFR1-Amplified ED-SCLC Databases were reviewed for studies that examined hENT1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results